Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside the bones that makes blood cells). AML is ...

iDenfy’s revamped AML Screening software now includes new risk categories, better PEP status labeling, and other built-in AML features Delaware, United States, October 29, 2025-- iDenfy, a global ...

AML Watcher has upgraded TruRisk to automate over 90% of Level 2 case management, the stage of the AML screening process where compliance teams have ...

M2T-CD33 has received orphan drug designation for AML, offering incentives like tax credits and market exclusivity. The M2T platform is a novel immunotherapy approach targeting CD33-positive leukemic ...